Earlier reports of high prevalence of thrombosis and related mortality has led to use of anticoagulants being part of the main treatment with varying results. Despite current large scale data showing credible benefits there are no studies done to determine the pattern of anticoagulation use and outcome in COVID patients in Ethiopia.